‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š National Institute of Health Sciences
¶•¨–ò•i•” Division of Biological Chemistry and Biologicals
@@@
yrINNzdrozitumab (List 65, 2011, Vol.25, No. 1, p55)
ypINNzdrozitumab (List 103, 2010, Vol.24, No. 2, p133)

y‰ðài˜a–ójz
IgG1ƒÉ, RƒqƒgTNFRSF10B (Žîᇉ󎀈öŽqŽó—e‘̃X[ƒp[ƒtƒ@ƒ~ƒŠ[ƒƒ“ƒo[10B, DR5, ×–EŽ€ˆöŽó—e‘Ì5, TRAIL-R2, TRAILŽó—e‘Ì2, TR-2, CD262), ƒqƒgƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì; RŽîᇖòD
H½ (ƒÁ1½C1-451)F[Homo sapiens VH (IGHV3-20*01 (91.80%) -(IGHD)-IGHJ2*01 R120>K,L123>T ) [8.8.14] (1-121) -IGHG1*03 CH1 R120>K (122-451)]D
L½(ƒÉ½C1'-213')F[Homo sapiens V-LAMBDA (IGLV3-19*01 (96.80%) -IGLJ3*01) [6.3.11] (1'-107') -IGLC3*03 (108'-213')]D
ƒWƒXƒ‹ƒtƒBƒhŒ‹‡‚̈ʒuF224-212', 224''-212''',230-230''C233-233''
“œ½•t‰ÁˆÊ’uF301, 301''

y•ªŽqŽ®z

yCAS”Ô†z912628-39-8

yJANz‹LÚ‚È‚µ
Copyright (C) @@@Division of Biological Chemistry and Biologicals@@@All rights reserved.